Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Between Bedside and Bench
  • Published:

miRNAs in the spotlight: Making 'silent' mutations speak up

Genetic mutations can cause numerous diseases. These alterations affect not only protein-coding genes but also regions that were until recently thought to be trivial in disease. In 'Bedside to Bench', David Salzman and Joanne Weidhaas examine a human study showing how a silent mutation impairs the binding of miR-196, increasing the risk for Crohn's disease. Therefore, alterations of miRNA target sites as pathogenic mechanism begs further investigation. miRNAs themselves can also be the root of disease. In 'Bench to Bedside', Carlo Croce peruses a study in vivo showing evidence of tumor addiction to miR-21 in a mouse model of cancer, which highlights the role of miRNAs as initiators of disease. Targeting these drivers will help to develop effective drugs.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Regulation of Crohn's disease by miRNA-196.

Mary Lou Quillen

References

  1. Easton, D.F. et al. Am. J. Hum. Genet. 81, 873–883 (2007).

    Article  CAS  Google Scholar 

  2. Brest, P. et al. Nat. Genet. 43, 242–245 (2011).

    Article  CAS  Google Scholar 

  3. Pastinen, T. & Hudson, T.J. Science 306, 647–650 (2004).

    Article  CAS  Google Scholar 

  4. Pastinen, T. et al. Hum. Mol. Genet. 15 Spec No 1, R9–R16 (2006).

    Article  CAS  Google Scholar 

  5. Bartel, D.P. Cell 116, 281–297 (2004).

    Article  CAS  Google Scholar 

  6. Esquela-Kerscher, A. & Slack, F.J. Nat. Rev. Cancer 6, 259–269 (2006).

    Article  CAS  Google Scholar 

  7. van Rooij, E. et al. Science 316, 575–579 (2007).

    Article  CAS  Google Scholar 

  8. Bartel, D.P. & Chen, C.Z. Nat. Rev. Genet. 5, 396–400 (2004).

    Article  CAS  Google Scholar 

  9. Saunders, M.A. et al. Proc. Natl. Acad. Sci. USA 104, 3300–3305 (2007).

    Article  CAS  Google Scholar 

  10. Abelson, J.F. et al. Science 310, 317–320 (2005).

    Article  CAS  Google Scholar 

  11. Chin, L.J. et al. Cancer Res. 68, 8535–8540 (2008).

    Article  CAS  Google Scholar 

  12. McCarroll, S.A. et al. Nat. Genet. 40, 1107–1112 (2008).

    Article  CAS  Google Scholar 

  13. Chen, C. et al. J. Cell. Mol. Med. 15, 14–23 (2011).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Joanne B Weidhaas.

Ethics declarations

Competing interests

J.B.W. is co-inventor on several patents and is the founder of a company, miraDx.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Salzman, D., Weidhaas, J. miRNAs in the spotlight: Making 'silent' mutations speak up. Nat Med 17, 934–935 (2011). https://doi.org/10.1038/nm0811-934

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0811-934

This article is cited by

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research